Optimal INR for prevention of stroke and death in atrial fibrillation: a critical appraisal

Thrombosis Research
Anders OdénR G Hart

Abstract

Patients with nonvalvular atrial fibrillation are at increased risk for systemic embolism, predominantly disabling stroke. To study how stroke and mortality rates vary with different degrees of anticoagulation reflected by the international normalised ratio (INR) we critically assess information from different sources. 1. Computerized search of the medical literature published between 1980 and July 2004 was performed using MEDLINE applied to various combinations of the search terms of atrial fibrillation, warfarin, anticoagulation, anticoagulation intensity, and INR, not restricted by language. 2. We performed a record linkage analysis with death hazard estimated as a continuous function of INR based on 21,967 patients. Similarly the risk of admission to hospital or death due to diseases of the vessels of the brain was estimated. 3. Re-analysis of data earlier published by Hylek et al. from year 2003. 1. One randomised study showed a significantly lower risk of stroke for mean INR 2.4 compared to mean INR 1.3 combined with aspirin. Remaining studies found INRs of 2-2.5 to be as efficacious as higher anticoagulation intensities.2. Mortality as well as risk of admission to hospital or death due to diseases of the vessels of the b...Continue Reading

Associated Clinical Trials

References

Jul 6, 1995·The New England Journal of Medicine·S C CannegieterE Briët
Jul 6, 1995·The New England Journal of Medicine·UNKNOWN European Atrial Fibrillation Trial Study Group
May 19, 2001·Japanese Circulation Journal·T NozawaUNKNOWN TOWARD Investigators. Toyama Warfarin Rational Dosage
Nov 9, 2002·BMJ : British Medical Journal·Anders Odén, Martin Fahlén
Feb 26, 2003·The New England Journal of Medicine·Paul M RidkerUNKNOWN PREVENT Investigators
May 21, 2003·Annals of Internal Medicine·Robert G HartUNKNOWN Stroke Prevention in Atrial Fibrillation Investigators
Aug 15, 2003·The New England Journal of Medicine·Clive KearonUNKNOWN Extended Low-Intensity Anticoagulation for Thrombo-Embolism Investigators
Sep 12, 2003·The New England Journal of Medicine·Elaine M HylekDaniel E Singer
Dec 4, 2003·JAMA : the Journal of the American Medical Association·Alan S GoDaniel E Singer
Mar 24, 2004·Archives of Internal Medicine·Marieke TornFrits R Rosendaal

❮ Previous
Next ❯

Citations

Nov 14, 2013·Journal of Thrombosis and Thrombolysis·Steven R SteinhublRichard C Becker
Nov 23, 2010·Journal of Atherosclerosis and Thrombosis·Selvakumar Velu, Gregory Y H Lip
May 23, 2007·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Natalie OakeCarl van Walraven
Jul 30, 2008·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Natalie OakeCarl van Walraven
Sep 10, 2011·Clinical Journal of the American Society of Nephrology : CJASN·Robert G HartCharles A Herzog
Dec 19, 2009·Vojnosanitetski pregled. Military-medical and pharmaceutical review·Tatjana PotparaNebojić Mujović
May 18, 2012·Herz·M Perrey, R Erbel
Dec 12, 2012·Current Heart Failure Reports·Ron Pisters, Gregory Y H Lip
Jan 23, 2016·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Mate VamosStefan H Hohnloser
Apr 7, 2010·International Journal of Cardiology·Stéphane EderhyAriel Cohen
Dec 24, 2015·Pharmacoepidemiology and Drug Safety·Maja HellfritzschAnton Pottegård
Jun 24, 2009·Clinica Chimica Acta; International Journal of Clinical Chemistry·Nikolina BabicKiang-Teck J Yeo
Nov 13, 2015·Thrombosis Research·Ashkan LabafPeter J Svensson
Aug 9, 2011·Stroke Research and Treatment·M Àngels FontAdrià Arboix
Sep 29, 2011·Thrombosis and Haemostasis·S Apostolakis, G Y H Lip
Jun 13, 2015·International Journal of Clinical Pharmacy·Jee Eun ChungHye Sun Gwak
Jan 14, 2009·Journal of Clinical Pharmacy and Therapeutics·F RyanS O'Shea
Nov 2, 2014·International Journal of Clinical Practice·J P BembenekA Członkowska
Apr 26, 2011·Journal of cardiology·Takeshi Yamashita
Mar 14, 2014·JACC. Heart Failure·Paul A Gurbel, Udaya S Tantry
Oct 23, 2010·Neurología : publicación oficial de la Sociedad Española de Neurología·A Gil Núñez
Dec 3, 2016·Basic & Clinical Pharmacology & Toxicology·Maja HellfritzschPer Damkier
May 16, 2014·Journal of Intensive Care Medicine·Payman Zamani, Ralph J Verdino
Aug 5, 2015·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Peter Y S OngHeng Joo Ng
Dec 19, 2017·Journal of Atrial Fibrillation·James A Reiffel
Apr 29, 2010·Srpski arhiv za celokupno lekarstvo·Tatjana Potpara, Miodrag Grujić
Nov 9, 2007·Circulation·Jeffrey L AndersonUNKNOWN Couma-Gen Investigators

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Brain Ischemia

Brain ischemia is a condition in which there is insufficient blood flow to the brain to meet metabolic demand. Discover the latest research on brain ischemia here.

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Acute Stroke

A stroke occurs when blood supply to the brain is interrupted depriving the brain of oxygen and nutrients. This feed focuses cerebrovascular accidents including ischemic and paralytic stroke.